MLNT News and Press, Melinta Therapeutics Inc - Ordinary Shares From 06/19/19

Gainers:  Melinta Therapeutics (NASDAQ: MLNT ) +180% . Arcturus Therapeutics (NASDAQ: ARCT ) +37% . Hebron Technology (NASDAQ: HEBT ) +26% . MYOS RENS Technology (NASDAQ: MYOS ) +22% . Armata Pharmaceuticals (NYSEMKT: ARMP ) +19% . AquaBounty Technologies (NASDAQ: AQB ) +19% . D...

Melinta Therapeutics (NASDAQ: MLNT ) +98%  on FDA approval of BAXDELA sNDA. More news on: Melinta Therapeutics, Inc., MYOS RENS Technology Inc., Axalta Coating Systems Ltd., Stocks on the move, Read more ...

The FDA has accepted Melinta Therapeutics' (NASDAQ: MLNT ) supplemental New Drug Application (sNDA) for BAXDELA (delafloxacin) for priority review. More news on: Melinta Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

~ Application Seeks to Expand Label to Include an Indication and Phase III Data for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia (CABP) ~ ~ PDUFA Date Set for October 24, 2019 ~ MORRISTOWN, N.J., June 19, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, ...

Gainers: Bluegreen Vacations (NYSE: BXG ) +35% . ArQule (NASDAQ: ARQL ) +34% . Avadel Pharmaceuticals (NASDAQ: AVDL ) +20% . Moxian (NASDAQ: MOXC ) +17% . Outlook Therapeutics (NASDAQ: OTLK ) +17% . BBX Capital (NYSE: BBX ) +15% . Puyi (NASDAQ: PUYI ) +11% . MYOS RENS Technolo...

The DISARM Act of 2019 provides the framework needed to stabilize the antimicrobial ecosystem, spur development of new infection-fighting drugs, and preserve the effectiveness of existing medicines for drug-resistant infections WASHINGTON , June 7, 2019 /PRNewswire/ -- The Antimi...

Someone’s sitting in the shade today because someone planted a tree a long time ago. - Warren Buffett Writing about antibiotic innovators is a quandary for me because I have to balance between the need for investment profits for investors vs. my social responsibility. It's an inte...

Gainers:  Charles & Colvard (NASDAQ: CTHR ) +34% . Buckeye Partners (NYSE: BPL ) +28% . Cardlytics (NASDAQ: CDLX ) +26% . G1 Therapeutics (NASDAQ: GTHX ) +24% . Westport Fuel Systems (NASDAQ: WPRT ) +21% . Cool Holdings (NASDAQ: AWSM ) +22% . Guardant Health (NASDAQ: GH ) +...

Melinta Therapeutics, Inc. (MLNT) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Susan Blum – Vice President-Finance and Chief Accounting Officer John Johnson – Chief Executive Officer Tim Simon – Chief Commercial Officer Peter...

Melinta Therapeutics (NASDAQ: MLNT ): Q1 GAAP EPS of -$2.34 beats by $2.67 . More news on: Melinta Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...